Adverse Prognostic Value of Persistent Office Blood Pressure Elevation in White Coat Hypertension

Hypertension

Volumn 66, Issue 2, 2015, Pages 437-444

  Mancia, Giuseppe ^a,b   Facchetti, Rita ^a   Grassi, Guido ^a,c   Bombelli, Michele ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c IRCCS MULTIMEDICA   (Italy)

Author keywords

antihypertensive agents; blood pressure; blood pressure monitoring, ambulatory; cardiovascular diseases; white coat hypertension

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; BODY SURFACE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; ELEVATED BLOOD PRESSURE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE MASS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SEX DIFFERENCE; WHITE COAT HYPERTENSION; AMBULATORY CARE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMPARATIVE STUDY; COMPLICATION; ITALY; LONGITUDINAL STUDY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; SURVIVAL RATE;

ADULT; AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ITALY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OFFICE VISITS; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; WHITE COAT HYPERTENSION;

EID: 84937542373     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.05367     Document Type: Article

References (40)

1. Mancia G, Fagard R, Narkiewicz K, Task Force Members 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281-1357. doi: 10.1097/01.hjh.0000431740.32696.cc
2. Mancia G, Zanchetti A., White-coat hypertension: Misnomers, misconceptions and misunderstandings. What should we do next? J Hypertens 1996;14:1049-1052.
3. Gosse P, Promax H, Durandet P, Clementy J., 'White coat' hypertension. No harm for the heart. Hypertension 1993;22:766-770.
4. Glen SK, Elliott HL, Curzio JL, Lees KR, Reid JL., White-coat hypertension as a cause of cardiovascular dysfunction. Lancet 1996;348:654-657. doi: 10.1016/S0140-6736(96)02303-3
5. Mancia G., White coat effect. Innocuous or adverse phenomenon? Eur Heart J 2000;21:1647-1648. doi: 10.1053/euhj.2000.2337
6. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G., Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994;24:793-801.
7. Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y., Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol 2005;46:508-515. doi: 10.1016/j.jacc.2005.03.070
8. Fagard RH, Cornelissen VA., Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: A meta-analysis. J Hypertens 2007;25:2193-2198. doi: 10.1097/HJH.0b013e3282ef6185
9. Pierdomenico SD, Cuccurullo F., Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: An updated meta analysis. Am J Hypertens 2011;24:52-58. doi: 10.1038/ajh.2010.203
10. Hansen TW, Kikuya M, Thijs L, Björklund-Bodegård K, Kuznetsova T, Ohkubo T, Richart T, Torp-Pedersen C, Lind L, Jeppesen J, Ibsen H, Imai Y, Staessen JA, IDACO Investigators Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: A meta-analysis of 7,030 individuals. J Hypertens 2007;25:1554-1564. doi: 10.1097/HJH.0b013e3281c49da5
11. Hänninen MR, Niiranen TJ, Puukka PJ, Johansson J, Jula AM., Prognostic significance of masked and white-coat hypertension in the general population: The Finn-Home Study. J Hypertens 2012;30:705-712. doi: 10.1097/HJH.0b013e328350a69b
12. Franklin SS, Thijs L, Hansen TW, International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators Significance of white-coat hypertension in older persons with isolated systolic hypertension: A meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertension 2012;59:564-571. doi: 10.1161/HYPERTENSIONAHA.111.180653
13. Ohkubo T, Imai Y, Tsuji I, Nagai K, Watanabe N, Minami N, Kato J, Kikuchi N, Nishiyama A, Aihara A, Sekino M, Satoh H, Hisamichi S., Relation between nocturnal decline in blood pressure and mortality. The Ohasama Study. Am J Hypertens 1997;10:1201-1207.
14. Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG, Imai Y, Ohkubo T, Kario K., Short- and long-term incidence of stroke in white-coat hypertension. Hypertension 2005;45:203-208. doi: 10.1161/01.HYP.0000151623.49780.89
15. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R., Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 2006;47:846-853. doi: 10.1161/01.HYP.0000215363.69793.bb
16. Mancia G, Bombelli M, Brambilla G, Facchetti R, Sega R, Toso E, Grassi G., Long-term prognostic value of white coat hypertension: An insight from diagnostic use of both ambulatory and home blood pressure measurements. Hypertension 2013;62:168-174. doi: 10.1161/HYPERTENSIONAHA.111.00690
17. Gustavsen PH, Høegholm A, Bang LE, Kristensen KS., White coat hypertension is a cardiovascular risk factor: A 10-year follow-up study. J Hum Hypertens 2003;17:811-817. doi: 10.1038/sj.jhh.1001643
18. Mancia G, Verdecchia P., Clinical value of ambulatory blood pressure: Evidence and limits. Circ Res 2015;116:1034-1045. doi: 10.1161/CIRCRESAHA.116.303755
19. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, Valagussa F, Bombelli M, Giannattasio C, Zanchetti A, Mancia G., Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation 2001;104:1385-1392.
20. Cuspidi C, Sala C, Tadic M, Rescaldani M, Grassi G, Mancia G., Is white-coat hypertension a risk factor for carotid atherosclerosis? A review and meta-analysis. Blood Press Monit 2015;20:57-63. doi: 10.1097/MBP.0000000000000094
21. Cuspidi C, Rescaldani M, Tadic M, Sala C, Grassi G, Mancia G., White-coat hypertension, as defined by ambulatory blood pressure monitoring, and subclinical cardiac organ damage: A meta-analysis. J Hypertens 2015;33:24-32. doi: 10.1097/HJH.0000000000000416
22. Bombelli M, Facchetti R, Carugo S, Madotto F, Arenare F, Quarti-Trevano F, Capra A, Giannattasio C, Dell'Oro R, Grassi G, Sega R, Mancia G., Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values. J Hypertens 2009;27:2458-2464. doi: 10.1097/HJH.0b013e328330b845
23. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr, Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14-22. doi: 10.1056/NEJM199901073400103
24. Zanchetti A, Hennig M, Hollweck R, Bond G, Tang R, Cuspidi C, Parati G, Facchetti R, Mancia G., Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: Findings in the European Lacidipine Study on Atherosclerosis (ELSA). Circulation 2009;120:1084-1090. doi: 10.1161/CIRCULATIONAHA.108.773119
25. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP., Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-1566. doi: 10.1056/NEJM199005313222203
26. Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Polo Friz H, Grassi G, Sega R., Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension 2009;54:226-232. doi: 10.1161/HYPERTENSIONAHA.109.129882
27. Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Grassi G, Sega R., Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension. J Hypertens 2009;27:1672-1678. doi: 10.1097/HJH.0b013e32832be5f9
28. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, Zanchetti A., Ambulatory blood pressure normality: Results from the PAMELA study. J Hypertens 1995;13(12 Pt 1)1377-1390.
29. Dubois D, Dubois EF., A formula to estimate the approximative surface area if height and weight are known. Arch Intern Med 1916;17:863-871.
30. WHO. Manual of International Statistical Classification of Diseases, Injuries and Causes of Death 1977 IXth revision Geneva WHO
31. Groppelli A, Omboni S, Parati G, Mancia G., Evaluation of noninvasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-hour intra-arterial blood pressure. Hypertension 1992;20:227-232.
32. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D., A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
33. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E., Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin outcome study. Hypertension 2005;46:156-161. doi: 10.1161/01.HYP.0000170138.56903.7a
34. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G., Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: Follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005;111:1777-1783. doi: 10.1161/01.CIR.0000160923.04524.5B
35. O'Brien E, Parati G, Stergiou G, European Society of Hypertension Working Group on Blood Pressure Monitoring European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013;31:1731-1768. doi: 10.1097/HJH.0b013e328363e964
36. Pierdomenico SD, Lapenna D, Bucci A, Di Iorio A, Neri M, Cuccurullo F, Mezzetti A., Cardiovascular and renal events in uncomplicated mild hypertensive patients with sustained and white coat hypertension. Am J Hypertens 2004;17:876-881. doi: 10.1016/j.amjhyper.2004.05.014
37. Triantafyllou A, Doumas M, Anyfanti P, Gkaliagkousi E, Zabulis X, Petidis K, Gavriilaki E, Karamaounas P, Gkolias V, Pyrpasopoulou A, Haidich AB, Zamboulis C, Douma S., Divergent retinal vascular abnormalities in normotensive persons and patients with never-treated, masked, white coat hypertension. Am J Hypertens 2013;26:318-325. doi: 10.1093/ajh/hps040
38. National Institute for Health and Care Excellence Hypertension: Clinical management of primary hypertension in adults (update). (Clinical guideline 127). August, 2011. http://guidance.nice.org.uk/CG127.
39. Cesana G, De Vito G, Ferrario M, Libretti A, Mancia G, Mocarelli P, Sega R, Valagussa F, Zanchetti A., Ambulatory blood pressure normalcy: The PAMELA Study. J Hypertens Suppl 1991 9 S17 S23
40. Collins R, MacMahon S., Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994;50:272-298.